TLR2 and neoplasm: Moreover, it was previously shown that the TLR2-L Pam3CSK4 improved the IFNγ response of tumor-infiltrating lymphocytes (TILs) after specific stimulation and had a slight advantage over Poly(I:C) and LPS in these assays [3].